Stocks News

LAST PRICE
203.6600
TODAY'S CHANGE (%)
Trending Up2.8300 (1.4092%)

Bid / Lots
140.0000/ 1
Ask / Lots
324.6800/ 2
Open / Previous Close
202.2300 / 200.8300
Day Range
Low 201.2600
High 205.6600
52 Week Range
Low 93.9500
High 214.9800
Volume
277,234
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

No documents available

Today
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 7 hours ago by GlobeNewswire
  7 hours ago by GlobeNewswire
  Companies Mentioned: BBIO
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: BBIO
Jul 18, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 9:37PM ET on Thursday Jul 18, 2024 by PR Newswire
  9:37PM ET on Thursday Jul 18, 2024 by PR Newswire
  Companies Mentioned: BBIO
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 9:37PM ET on Thursday Jul 18, 2024 by Dow Jones
  9:37PM ET on Thursday Jul 18, 2024 by Dow Jones
  Companies Mentioned: BBIO
Jul 17, 2024
- Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024, from 4:05PM ET on Wednesday Jul 17, 2024 by PR Newswire
  4:05PM ET on Wednesday Jul 17, 2024 by PR Newswire
  Companies Mentioned: VKTX
- Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024, from 4:05PM ET on Wednesday Jul 17, 2024 by Dow Jones
  4:05PM ET on Wednesday Jul 17, 2024 by Dow Jones
  Companies Mentioned: VKTX
Jul 16, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 4:13PM ET on Tuesday Jul 16, 2024 by Newsfile
  4:13PM ET on Tuesday Jul 16, 2024 by Newsfile
  Companies Mentioned: BBIO
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 4:12PM ET on Tuesday Jul 16, 2024 by Dow Jones
  4:12PM ET on Tuesday Jul 16, 2024 by Dow Jones
  Companies Mentioned: BBIO
- JMP Securities Raises Price Target on Madrigal Pharmaceuticals to $385 From $381, Maintains Market Outperform Rating, from 11:14AM ET on Tuesday Jul 16, 2024 by MT Newswires
  11:14AM ET on Tuesday Jul 16, 2024 by MT Newswires
  Companies Mentioned: MDGL
- DJ Madrigal Pharmaceuticals Is Maintained at Market Outperform by JMP Securities, from 11:11AM ET on Tuesday Jul 16, 2024 by Dow Jones
  11:11AM ET on Tuesday Jul 16, 2024 by Dow Jones
  Companies Mentioned: MDGL

Krystal Biotech Inc
NASDAQ:KRYSUnited States

Search Criteria

Peers Headlines

Today

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 7 hours ago by GlobeNewswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 7 hours ago by Dow Jones

Jul 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 9:37PM ET on Thursday Jul 18, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 9:37PM ET on Thursday Jul 18, 2024 by Dow Jones

Jul 17, 2024

Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024, from 4:05PM ET on Wednesday Jul 17, 2024 by PR Newswire

Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024, from 4:05PM ET on Wednesday Jul 17, 2024 by Dow Jones

Jul 16, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 4:13PM ET on Tuesday Jul 16, 2024 by Newsfile

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma, Inc. - BBIO, from 4:12PM ET on Tuesday Jul 16, 2024 by Dow Jones

JMP Securities Raises Price Target on Madrigal Pharmaceuticals to $385 From $381, Maintains Market Outperform Rating, from 11:14AM ET on Tuesday Jul 16, 2024 by MT Newswires

DJ Madrigal Pharmaceuticals Is Maintained at Market Outperform by JMP Securities, from 11:11AM ET on Tuesday Jul 16, 2024 by Dow Jones